DOT and VDOT: Video DOT Directly Observed Therapy. Opioid Substitution Therapy (OST)

DOT and VDOT: Video DOT Directly Observed Therapy. Opioid Substitution Therapy (OST)
  • Directly Observed Therapy (DOT)
  • Video DOT (VDOT)
  • Tuberculosis (TB)
  • Opioid Substitution Therapy (OST)
  • HIV PrEP
  • Hepatitis C

  • Tuberculosis: Improve tuberculosis (TB) treatment adherence and minimize the risk of developing drug resistant TB, health agencies worldwide recommend directly observed therapy (DOT) to ensure that patients are ingesting all of their TB medications. While the benefits of DOT are clear, costs, human resources, and other barriers make DOT impractical or impossible in many settings. Video DOT (VDOT) reduces the barriers making remote patient observation feasible and cost-effective. Tamper Resistant e-pill Dispenser

    Opioid Substitution Therapy: Opioid substitution therapy (OST) aids in curbing opioid use. Heroin, Cocaine and Prescription Opioids (OxyContin, Vicodin, fentanyl, etc.) by occupying the opioid receptors in the brain and reducing or blocking the effects of heroin and other opioids. Patients enrolled in OST are able to stop using opioids and begin to rebuild their lives through counseling and pro-social activities because OST helps to reduces their cravings and feelings of withdrawal. However, in early OST treatment, patients are required by federal and state regulations to have their therapy administered by DOT. While take-home doses can be earned by trusted patients over time, the requirement for directly observed therapy places a large burden on both the patient and provider, which can make the process of recovery that much harder. Tamper Resistant e-pill Dispenser

    HIV PrEP: HIV PrEP (pre-exposure prophylaxis) is a new prevention method in which people without HIV take a daily pill to reduce their risk of becoming infected. Studies have show that PrEP can reduce the risk of HIV infection by 92%, but only when PrEP is taken as directed. People who use PrEP must commit to taking the drug every day and seeing their health care provider for follow-up every 3 month. While DOT is not required for patients taking PrEP, it can be help them to take their pills consistently, especially in the beginning when patients are learning to make PrEP part of their daily regimen. Tamper Resistant e-pill Dispenser

    Hepatitis C: It is estimated that 2.7-3.9 million people in the United States have chronic hepatitis C, and is the leading indication for liver transplants. Highly effective treatments are now available that eliminate the hepatitis C virus so patients can be cured and will no longer be able to spread the virus to others. Hepatitis C virus infection is treated with antiviral medications intended to clear the virus from the patient's body. The goal of treatment is to eliminate the virus from the patient so liver damage stops. Recent clinical advances have reduced treatment time to approximately three months with 95% effectiveness. However, once-daily oral medications must be taken consistently to cure the patient and avoid having the virus become resistant to the new drugs. To ensure patients have taken their daily dose of medication, DOT / VDOT can be used to monitor Hepatitis C treatment adherence. Tamper Resistant e-pill Dispenser
    Scroll to top